T1	Condition 13 30	diabetes mellitus
T2	Qualifier 44 78	World Health Organization criteria
R1	Has_qualifier Arg1:T1 Arg2:T2	
T3	Drug 96 103	insulin
T4	Procedure 81 90	treatment
T5	Drug 110 133	oral hypoglycemic agent
T6	Multiplier 135 140	twice
T7	Measurement 141 168	random glucose measurements
T8	Value 169 189	major than 200 mg/dl
T9	Measurement 196 211	fasting glucose
T10	Value 212 232	major than 140 mg/dl
R2	Has_value Arg1:T9 Arg2:T10	
R3	Has_multiplier Arg1:T7 Arg2:T6	
R4	Has_value Arg1:T7 Arg2:T8	
*	OR T7 T9 T4
*	OR T3 T5
T11	Scope 96 133	insulin or an oral hypoglycemic agent
R5	Has_scope Arg1:T4 Arg2:T11	
T12	Scope 81 232	treatment with insulin or an oral hypoglycemic agent, twice random glucose measurements major than 200 mg/dl, or a fasting glucose major than 140 mg/dl
T13	Scope 13 78	diabetes mellitus according to World Health Organization criteria
R6	Subsumes Arg1:T13 Arg2:T12	
T14	Condition 235 240	Ulcer
T15	Qualifier 256 260	legs
T16	Qualifier 264 268	feet
T17	Measurement 270 275	stage
T18	Value 276 285	III or IV
R7	Has_value Arg1:T17 Arg2:T18	
T19	Qualifier 287 315	Wagner Classification System
R8	Has_qualifier Arg1:T17 Arg2:T19	
*	OR T15 T16
T20	Scope 256 268	legs or feet
R9	Has_scope Arg1:T14 Arg2:T20	
*	OR T14 T17
T21	Informed_consent 318 416	The subject agrees to comply with study protocol requirements and all follow up visit requirements
